Comprehensive Laboratory Evaluation of a Lateral Flow Assay for the Detection of Yersinia pestis

We conducted a comprehensive, multiphase laboratory evaluation of the Plague BioThreat Alert (BTA) test, a lateral flow immunoassay (LFA), for the rapid detection of . The study was conducted in 7 phases at 2 sites to assess the performance of the LFA. The limit of detection (LOD) was determined usi...

Full description

Saved in:
Bibliographic Details
Published inHealth security Vol. 17; no. 6; p. 439
Main Authors Prentice, Kristin W, DePalma, Lindsay, Ramage, Jason G, Sarwar, Jawad, Parameswaran, Nishanth, Petersen, Jeannine, Yockey, Brook, Young, John, Joshi, Mrinmayi, Thirunavvukarasu, Nagarajan, Singh, Ajay, Chapman, Carol, Avila, Julie R, Pillai, Christine A, Manickam, Gowri, Sharma, Shashi K, Morse, Stephen A, Venkateswaran, Kodumudi Venkat, Anderson, Kevin, Hodge, David R, Pillai, Segaran P
Format Journal Article
LanguageEnglish
Published United States 01.12.2019
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:We conducted a comprehensive, multiphase laboratory evaluation of the Plague BioThreat Alert (BTA) test, a lateral flow immunoassay (LFA), for the rapid detection of . The study was conducted in 7 phases at 2 sites to assess the performance of the LFA. The limit of detection (LOD) was determined using both a virulent and avirulent strain of , CO99-3015 (10 CFU/ml) and A1122 (10 CFU/ml), respectively. In the other phases, 18 strains, 20 phylogenetic near-neighbor strains, 61 environmental background microorganisms, 26 white powders, and a pooled aerosol sample were also tested. A total of 1,110 LFA test results were obtained, and their analysis indicates that this LFA had a sensitivity of 97.65% and specificity of 96.57%. These performance data are important for accurate interpretation of qualitative results arising from testing suspicious white powders and aerosol samples in the field. Any positive specimen in this assay is considered presumptive positive and should be referred to the Centers for Disease Control and Prevention Laboratory Response Network for additional testing, confirmation, and characterization for an appropriate public health response.
ISSN:2326-5108
DOI:10.1089/hs.2019.0094